|
ZNF816A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.089550E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.120580E-01 |
| Normal-vs-Stage2 |
8.147600E-01 |
| Normal-vs-Stage3 |
5.073600E-01 |
| Normal-vs-Stage4 |
7.624200E-01 |
| Stage1-vs-Stage2 |
4.422200E-01 |
| Stage1-vs-Stage3 |
8.010400E-02 |
| Stage1-vs-Stage4 |
3.514600E-01 |
| Stage2-vs-Stage3 |
4.685000E-01 |
| Stage2-vs-Stage4 |
6.912200E-01 |
| Stage3-vs-Stage4 |
8.293600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.207600E-02 |
| Normal-vs-AfricanAmerican |
9.624200E-01 |
| Normal-vs-Asian |
7.893800E-01 |
| Caucasian-vs-AfricanAmerican |
3.734200E-02 |
| Caucasian-vs-Asian |
4.715400E-01 |
| AfricanAmerican-vs-Asian |
8.463800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.633450E-01 |
| Normal-vs-Female |
1.148560E-01 |
| Male-vs-Female |
5.950800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.816800E-01 |
| Normal-vs-Extreme_Weight |
5.238600E-01 |
| Normal-vs-Obese |
7.319600E-02 |
| Normal-vs-Extreme_Obese |
1.023400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.961000E-01 |
| Normal_Weight-vs-Obese |
2.386800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.558790E-01 |
| Extreme_Weight-vs-Obese |
2.181200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.271240E-01 |
| Obese-vs-Extreme_Obese |
3.323700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.947600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.198200E-02 |
| Normal-vs-Age(61-80Yrs) |
2.625800E-01 |
| Normal-vs-Age(81-100Yrs) |
2.782600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.532000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.738000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.987000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.511000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.370100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.134800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.053900E-02 |
| Normal-VS-Type2 PRCC |
9.873700E-02 |
| Normal-VS-KIRP CIMP |
4.390800E-01 |
| Normal-VS-Unclassified PRCC |
1.305230E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.10830000030904E-07 |
| Type1 PRCC-VS-KIRP CIMP |
9.964200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.295200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.518200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.044340E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.878020E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.475800E-01 |
| Normal-vs-N1 |
9.328000E-01 |
| Normal-vs-N2 |
2.603700E-02 |
| N0-vs-N1 |
7.823200E-01 |
| N0-vs-N2 |
5.168200E-02 |
| N1-vs-N2 |
1.136980E-01 |
|
|
